Auteur: Toufigh Gordi

Bret Berner, Ph D, is a pharmaceutical consultant in drug delivery, formulation, and pharmacokinetics. He was formerly Director of Basic Pharmaceutics Research at Ciba-Geigy, Vice President of Development at Cygnus Therapeutics, and Chief Scientific Officer at Depomed. Toufigh Gordi, Ph D, is a Senior Director of clinical pharmacology at Rigel Pharmaceuticals, with extensive experience in using pharmacokinetic and pharmacodynamic modeling to advance candidate drug molecules from preclinical through late phase confirmatory clinical studies. Heather A. E. Benson, Ph D, is Associate Professor in Curtin Medical School at Curtin University, Australia where she leads the Skin Delivery Research Group Michael S. Roberts, Ph D, is Professor of Therapeutics and Pharmaceutical Science at the University of South Australia and Professor of Clinical Pharmacology and Therapeutics at the University of Queensland.